ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.154,61
0,52%
Dow Jones
38.705,82
0,08%
Euro vs US Dollar
1,07757
0,17%
Bitcoin
63.568,50
-0,67%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Dr Reddys Laboratories Ltd (RDY)

  7. Dr Reddys Laboratories Ltd (RDY) News

RDY

Dr Reddys Laboratories (RDY)

Dr Reddys Laboratories Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:RDY
DatumZeitQuelleÜberschriftSymbolFirma
03/05/202414h00Business WireDr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.NYSE:RDYDr Reddys Laboratories Ltd
22/03/202412h00GlobeNewswire Inc.Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in IndiaNYSE:RDYDr Reddys Laboratories Ltd
19/03/202412h00Business WireDr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UKNYSE:RDYDr Reddys Laboratories Ltd
04/03/202412h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
01/03/202412h22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
29/02/202412h57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
29/02/202412h22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
26/02/202412h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
23/02/202412h22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
21/02/202414h43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
20/02/202412h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
15/02/202412h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
12/02/202418h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
05/02/202416h53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
02/02/202412h07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
31/01/202415h44Business WireDr. Reddy’s Q3 & 9M FY24 Financial ResultsNYSE:RDYDr Reddys Laboratories Ltd
31/01/202413h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
30/01/202420h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
30/01/202419h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
30/01/202417h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
30/01/202412h36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
19/01/202416h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
16/01/202419h41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
16/01/202417h34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
16/01/202414h58Dow Jones NewsIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky News ReportsNYSE:RDYDr Reddys Laboratories Ltd
16/01/202412h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
10/01/202414h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
08/01/202412h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
03/01/202412h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
03/01/202412h00Business WireDr. Reddy's Announces the Acquisition of MenoLabs®, a Leading Women’s Health and Dietary Supplements Portfolio of BrandsNYSE:RDYDr Reddys Laboratories Ltd
 Showing the most relevant articles for your search:NYSE:RDY

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
TG
D7G
Nel ASA
DBI
SDXP
SDAX
CCOM
US30
US 30
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
TG
DBK
Deutsche Bank
NYSE
NKE
Nike
TG
TUI1
Tui
NYSE
XOM
Exxon Mobil
TG
MBG
MercedesBenz
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten